PATENT CLAIM ANALYSIS

Application Number: 15959419
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "232800"]

Abstract:
Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R 1  to R 6 , X 1  to X 4 , and n are the same as defined in claim  1.

Claim (Index 18):
The method according to  claim 17 , further comprising:\n G\u2033) reducing \u2014NO 2  to \u2014NH 2  through hydrogenation of the compound generated in the introducing (F\u2033) to generate a final product.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 91.0
- Lexical Diversity: 1.61538
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15102968', '11849230', '12946759', '13035640', '13138227']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7480339860314047
- 35 USC 102 Novelty (BERT): 0.5759356390897551
- Combined Prediction Score: 0.7308241513372398
- Mean Citation Score: 370.249616
- Max Citation Score: 649.2651
- Similarity Product: 333.8455561722815

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test